Literature DB >> 15316964

Paternal transmission of fragile X syndrome.

Susan Zeesman1, Lonnie Zwaigenbaum, Donald T Whelan, Randi J Hagerman, Flora Tassone, Sherryl A M Taylor.   

Abstract

We present a family in which a fragile X mosaic male, who carries both premutation and full mutation alleles in his peripheral blood leukocytes, has a daughter with both premutation and partially methylated full mutation alleles and a significant developmental disability. To our knowledge, this is the first report of such an occurrence and it challenges current thinking about the expansion and transmission of unstable FMR1 alleles from men to their daughters. It is currently accepted that neither males with premutations nor full mutations are at risk for having daughters with full mutations and fragile X syndrome. The sperm cells of full mutation males are thought to carry only premutation alleles. These alleles, when transmitted through a male, regardless of his cognitive status, are thought to be unable to expand to full mutations in the next generation. In effect, the expansion from premutation to full mutation has only been observed through female meioses. The sperm cells in the father in this family have been shown to contain only alleles in the premutation range. Since his daughter has both premutation and full mutation alleles the expansion to full mutation in this case must have occurred postzygotically. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316964     DOI: 10.1002/ajmg.a.30191

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

1.  Longitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing.

Authors:  Lisa M Pastore; Logan B Karns; Karen Ventura; Myra L Clark; Richard H Steeves; Nancy Callanan
Journal:  J Genet Couns       Date:  2013-06-14       Impact factor: 2.537

2.  Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.

Authors:  Allyn McConkie-Rosell; Brenda Finucane; Amy Cronister; Liane Abrams; Robin L Bennett; Barbara J Pettersen
Journal:  J Genet Couns       Date:  2005-08       Impact factor: 2.537

Review 3.  Fragile X syndrome: the FMR1 CGG repeat distribution among world populations.

Authors:  Emmanuel Peprah
Journal:  Ann Hum Genet       Date:  2011-12-21       Impact factor: 1.670

4.  Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency.

Authors:  Sebastien Jacquemont; Stefanie Birnbaum; Silke Redler; Peter Steinbach; Valérie Biancalana
Journal:  Eur J Hum Genet       Date:  2011-05-04       Impact factor: 4.246

Review 5.  Mechanisms of the FMR1 Repeat Instability: How Does the CGG Sequence Expand?

Authors:  Elisabetta Tabolacci; Veronica Nobile; Cecilia Pucci; Pietro Chiurazzi
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

Review 6.  Instability and chromatin structure of expanded trinucleotide repeats.

Authors:  Vincent Dion; John H Wilson
Journal:  Trends Genet       Date:  2009-06-18       Impact factor: 11.639

7.  Fragile X syndrome: diagnostic and carrier testing.

Authors:  Stephanie Sherman; Beth A Pletcher; Deborah A Driscoll
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

8.  Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Elaine Spector; Andrea Behlmann; Kathryn Kronquist; Nancy C Rose; Elaine Lyon; Honey V Reddi
Journal:  Genet Med       Date:  2021-04-01       Impact factor: 8.822

9.  DNA repair/replication transcripts are down regulated in patients with Fragile X Syndrome.

Authors:  Huichun Xu; Mónica A Rosales-Reynoso; Patricio Barros-Núñez; Emmanuel Peprah
Journal:  BMC Res Notes       Date:  2013-03-11

Review 10.  The FMR1 gene, infertility, and reproductive decision-making: a review.

Authors:  Lisa M Pastore; Joshua Johnson
Journal:  Front Genet       Date:  2014-07-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.